About Jeffrey Kossak
Form D filings for Alphyn Biologics in 2024 list Jeffrey Kossak as director.
Jeffrey Kossak first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Kossak in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Kossak works with at each company, as listed on that company's latest Form D.
Alphyn Biologics, Inc. · Form D, May 20, 2024
SP
Steven Pentelnik
Executive officer
GP
Gary Pekoe
Executive officer and director
AM
Adel Mikhail
Director
RG
Roger Griggs
Director
NK
Neal Koller
Chief Executive Officer and director